NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marshall UristEVP Research Investments2026-01-2320,000$40.26
$805.10kSell
Terrance P. CoyneEVP CFO2026-01-2065,832$39.35
$2.59MSell
Terrance P. CoyneEVP CFO2026-01-203,750$39.35
$147.56kSell
Marshall UristEVP Research Investments2026-01-1620,000$39.52
$790.34kSell
Marshall UristEVP Research Investments2026-01-0920,000$40.78
$815.64kSell
Marshall UristEVP Research Investments2026-01-0220,000$38.48
$769.66kSell
Terrance P. CoyneEVP CFO2026-01-0265,832$38.42
$2.53MSell
Terrance P. CoyneEVP CFO2026-01-023,750$38.42
$144.06kSell
Bonnie L. BasslerDirector2025-12-31967$38.74
$37.46kBuy
Marshall UristEVP Research Investments2025-12-2620,000$39.32
$786.38kSell

1 of 5

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley7.65%44,163,954$1.79BInstitution
Adage Capital Partners GP LLC6.71%38,714,280$1.57BInsider
Fmr LLC4.85%27,986,714$1.13BInstitution
Capital International Investors4.71%27,212,694$1.10BInstitution
Blackrock Inc4.54%26,200,503$1.06BInstitution
1978 Sicaf Sif Sa 1. Gg3.83%22,081,156$893.62MInsider
1978 Sicaf Sif Sa Gg3.71%21,426,170$867.12MInsider
Baillie Gifford Co3.01%17,372,502$703.07MInstitution
Swedbank Ab2.11%12,200,270$493.74MInstitution
Adage Capital Partners GP LLC2.07%11,965,633$484.25MInstitution

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX56.76%17.29%Net SellingNet Selling
GMAB96.17%0.00%
UTHR86.71%13.29%Net SellingNet Selling
INCY77.71%22.29%Net SellingNet Selling
RVMD90.69%9.31%Net SellingNet Selling

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 56.76% institutional shareholders, 17.29% Royalty Pharma insiders, and 25.95% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.71% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $1.58B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.